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JunD Reduces Tumor Angiogenesis by
Protecting Cells from Oxidative Stress
inducing glycolysis, erythropoiesis, and angiogenesis.
The transcription factor HIF (hypoxia-inducible factor)
is an essential element of this cellular response (for
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The hypoxic induction of angiogenesis is a hallmarkSummary
of many pathologies, such as solid tumor progression.
Tumor angiogenesis increases tumor growth beyond aReactive oxygen species (ROS) are implicated in the
limited size (i.e., 1–2 mm in diameter) and promotespathophysiology of various diseases, including can-
the metastatic spread of tumor cells (for review, seecer. In this study, we show that JunD, a member of
Folkman [1990]). One example of such adaptive prolifer-the AP-1 family of transcription factors, reduces tumor
ative and angiogenic functions is provided by the Rasangiogenesis by limiting Ras-mediated production of
oncogene. Constitutively activated forms of Ras haveROS. Using junD-deficient cells, we demonstrate that
been described as the most common mutated oncogeneJunD regulates genes involved in antioxidant defense,
detected in human tumors (Barbacid, 1987; Bos, 1989).H2O2 production, and angiogenesis. The accumulation Constitutive Ras signaling results in loss of contact inhi-of H2O2 in junD/ cells decreases the availability of bition and abnormal cell proliferation (Peeper et al.,
FeII and reduces the activity of HIF prolyl hydroxylases
1997). Moreover, overexpression of Ras has been linked
(PHDs) that target hypoxia-inducible factors- (HIF) to vascularization of tumors (Bergers and Benjamin,
for degradation. Subsequently, HIF- proteins accu- 2003). Indeed, transformation by Ras stabilizes HIF-1
mulate and enhance the transcription of VEGF-A, a and upregulates the transcription of VEGF-A. Activated
potent proangiogenic factor. Our study uncovers the forms of Ras have also been correlated with the produc-
mechanism by which JunD protects cells from oxida- tion of high amounts of reactive oxygen species (ROS)
tive stress and exerts an antiangiogenic effect. Fur- (Irani et al., 1997). Moreover, chemical antioxidants in-
thermore, we provide new insights into the regulation hibit the mitogenic activity of Ras, indicating that ROS
of PHD activity, allowing immediate reactive adapta- participate directly in malignant transformation. Finally,
tion to changes in O2 or iron levels in the cell. ROS stabilize HIF-1 protein and induce production of
angiogenic factors by tumor cells (Chandel et al., 1998).
Introduction Oxidative stress is thus assumed to play a key role in
tumor angiogenesis and cancer progression.
Maintaining oxygen (O2) homeostasis is essential for sur- The AP-1 transcription factor plays a central role in
vival. Change in O2 pressure is a major stimulus that modulating transformation by Ras (for review, see Mechta-
elicits rapid cellular responses. Hypoxia leads to the Grigoriou et al. [2001]). AP-1 is composed of Jun family
transcription of genes that help supply O2 to tissues by members (c-Jun, JunB, and JunD) that can form either
homo- or heterodimers among themselves or with the
Fos family members (c-Fos, FosB, Fra1, Fra2). The dif-*Correspondence: fmechta@pasteur.fr
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ferent AP-1 dimers exhibit rather similar DNA binding and 1Ab). In contrast, tumors derived from the three
independent RasJunD cell lines remained pale andspecificities but differ in their transactivation efficienc-
ies. Studies of AP-1 functions in cell culture and in poorly vascularized (n  36 tumors) (Figures 1Ac and
1Ad). Histological analysis of sections stained with anmouse models reveal distinct roles for each member
(for reviews, see Wagner [2001]; Shaulian and Karin endothelial-specific antibody (PECAM-1) confirmed
these macroscopic observations (Figure 1B). The vascu-[2002]). The three jun genes exhibit different expression
patterns during cell cycle progression. While c-jun and lar density was reduced in tumors from RasJunD
clones (Figures 1Be–1Bh and 1C) compared to Ras cellsjunB behave as immediate early genes upon mitogenic
stimulation, junD expression remains almost invariant, (Figures 1Ba–1Bd and 1C). RasJunD tumors had fewer
vessels with occasional avascular areas (Figure 1Bg).and its product is partially degraded upon serum-
induced reentry into the cell cycle (Pfarr et al., 1994). Finally, the proportion of large-sized vessels was higher
in Ras- than in RasJunD-derived tumors (Figure 1C),Moreover, overexpression of JunD in immortalized fibro-
blasts slows their proliferation and induces accumula- indicating that overexpression of JunD reduces the
number and the size of the blood vessels.tion in the G1 phase. Furthermore, immortalized fibro-
blasts lacking junD (junD/) display higher proliferation
rates than their wild-type (wt) counterparts (Weitzman et JunD Controls the Rate of VEGF-A Transcription
al., 2000). In contrast, c-Jun overexpression stimulates S Many oncogenic pathways trigger induction of the major
phase entry, and c-Jun function is required for cell cycle angiogenic factor VEGF-A (for review, see Ferrara et al.
progression (Kovary and Bravo, 1991; Wisdom et al., [2003]). Moreover, even modest decreases in VEGF-A
1999). expression led to a marked reduction of tumor angio-
The antagonistic balance in the function of the differ- genesis (Benjamin and Keshet, 1997). We therefore
ent Jun members is also illustrated by their respective measured the level of VEGF-A mRNA expression by
roles in transformation. While c-Jun cooperates with quantitative (Q) real-time RT-PCR experiments. JunD
Ras, excess JunD partially suppresses the transformed overexpression significantly decreased the level of
phenotype of the cells (Pfarr et al., 1994; Mechta et al., VEGF-A mRNA in tumors (Figure 2A) and Ras-trans-
1997). The negative effect of JunD is mainly attributed formed cells (Figure 2B). Upon hypoxia, the accumula-
to its ability to slow fibroblast growth. Since angiogen- tion of VEGF-A mRNA proceeds by both transcriptional
esis is a crucial step in tumor progression, we investi- induction and stabilization of its mRNA. To evaluate the
gated the function of JunD in this process. In this paper, contribution of these two processes, we measured the
we show that overexpression of JunD downregulates level of the primary transcript of VEGF-A by amplification
VEGF-A expression and reduces angiogenesis in tu- of an intron (intron 4). Results shown in Figure 2B confirm
mors. Moreover, we demonstrate that JunD protects that JunD reduced the rate of VEGF-A transcription in
cells from oxidative stress by limiting ROS production. Ras-transformed cells.
Microarray analysis reveals that JunD acts both on cellu- To further assess the role of JunD in the regulation
lar antioxidant defense systems and H2O2 production. of VEGF-A, we measured the level of VEGF-A mRNA in
Taking advantage of junD-deficient cells, we show that immortalized fibroblasts derived from junD/ embryos.
accumulation of oxidants such as H2O2 decreases the Three independent wt and junD/ cell lines were iso-
proportion of PHD in FeII oxidation state, thereby inhib- lated and used for further experiments (see Supplemen-
iting its enzymatic activity. This inhibition impairs the tal Figure S1). Steady-state levels of VEGF-A mRNA
degradation of HIF-1 under normoxia and enhances were increased in junD/ fibroblasts as compared to
VEGF-A transcription. This study provides new insights control cells (2.5-fold) (Figure 2C). The primary transcript
into the mechanism of iron-dependent regulation of PHD of VEGF-A exhibited similar amplification as its mRNA
activity and uncovers how JunD displays an antiangio- in junD/ cells, confirming that JunD-mediated effect
genic effect by promoting HIF- degradation. is transcriptional. Finally, to verify that the accumula-
tion of VEGF-A mRNA in junD/ cells was not due to
the immortalization protocol, we checked the level of
Results VEGF-A transcripts in junD/ embryos (10.5 dpc) by
semiquantitative RT-PCR (Figure 2D). Pools of four em-
Overexpression of JunD Reduces Ras-Induced bryos were analyzed to avoid individual variations. We
Tumor Angiogenesis repeatedly detected an upregulation of VEGF-A expres-
We have previously shown that JunD overexpression sion in junD/ embryos. Thus, the enhanced VEGF-A
slows Ras-induced tumor growth (Pfarr et al., 1994). In transcription results from the deletion of junD and is
this study, we used 3T3 cells transformed by the Ki-ras independent of the immortalization state of the cells.
oncogene (Ras) and three independent clonal lines with The upregulation of VEGF-A transcription in the
increased JunD expression (RasjunD). After subcuta- junD/ cell lines was confirmed by transient transfection
neous injection into nude mice, we repeatedly observed assays using the human VEGF-A promoter (P-1176) (Fig-
that tumors derived from the different RasJunD cell ure 2E), a construct that triggers VEGF-A expression
lines were paler than those derived from Ras cells. We under hypoxic conditions (Ikeda et al., 1995). Deletion
therefore monitored the vascular content of these tu- of the region (1176 to 888) completely abolished
mors when they had reached the same size. Tumors the effect of junD (Figure 2E). Since the deleted region
derived from Ras-transformed cells were highly vascu- contains a potential AP-1 binding site, we tested if AP-1
may directly regulate the promoter. Cotransfection oflarized and hemorrhagic (n  18 tumors) (Figures 1Aa
junD Regulates Oxidative Stress and Angiogenesis
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Figure 1. Overexpression of JunD Reduces Tumor Angiogenesis
(A) Representative views of tumors derived from Ras- (Ras) (Aa and Ab) and JunD-overexpressing Ras-transformed fibroblasts (RasJunD)
(Ac and Ad). The same phenotype was observed with three independent cell lines. (B) Sections and histological analysis (PECAM-1 immunostain-
ing) of tumors derived from Ras (Ba–Bd) and RasJunD (Be–Bh) cells. (C) Vascular density (vessels/mm2) of total, large-sized (diameter  30
m) and small-sized (diameter  30 m) blood vessels in Ras- and RasJunD-derived tumors. Arrowheads in (B) indicate typical large-sized
vessels used for this quantification. Numbers below indicate the percentage of large- and small-sized vessels in the respective populations.
Quantification (means 	 SD) resulted from analysis of four independent tumors per cell type and considered at least ten fields for each tumor.
Scale bars, 12.5 mm (A) and 200 m (B).
different AP-1 components (i.e., JunD, c-Jun, JunD ner. This effect might be mediated by the HIF binding
site, which has also been removed in the P-888 con-c-Fos, or c-JuncFos) with the P-1176 promoter did
not modify its activity (data not shown), indicating that struct. Accordingly, specific mutation of the HIF binding
site in the VEGF-A promoter (P-mutHIF) that is knownJunD controls VEGF-A transcription in an indirect man-
Cell
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Figure 2. JunD Controls VEGF-A Transcription
(A) Relative levels of VEGF-A mRNA in Ras and RasJunD tumors. 2-microglobulin was used as internal control of amplification. Results
are means of four independent tumors per genotype.
(B) Relative levels of VEGF-A mRNA (left bar graph) and its primary transcript (right bar graph) in Ras and RasJunD independent cell lines.
Data are expressed as means 	 SD (n  3 cell lines in triplicate)
(C) Relative levels of VEGF-A mRNA (left panel) and its primary transcript (right panel) in wt and junD/ cell lines. Values are means 	 SD of
experiments reproduced in triplicate for three independent cell lines per genotype.
(D) VEGF-A mRNA levels in wt and junD/ embryos (n  4 embryos per genotype), detected by semiquantitative RT-PCR. -actin is used as
invariant control, and four successive cycles in the linear phase of amplification are shown.
(E) (Left panel) Schematic drawings of the full-length (P-1176) human VEGF-A promoter, a deleted version (P-888), and a mutated variant in
the HIF binding site (P-mutHIF). The start site of transcription is referred to as 1. (Right panel) Activity of full-length, deleted, and mutated
versions of the VEGF-A promoter in wt and junD/ fibroblasts. Data are means 	 SD (n  2 cell lines in triplicate).
to abolish HIF-1 DNA binding (Wang and Semenza, 1993) the small interfering RNA (siRNA) approach (Figure 3A).
HIF-1 siRNA shut down HIF-1 expression, whereasstrongly affected the JunD-dependent effect (Figure 2E).
the D-HIF (Drosophila HIF) siRNA control had no effect
when compared to untreated cells (Figure 3A and seeHIF1 and HIF2 Accumulate
in junD/ Fibroblasts Supplemental Figure S2 at http://www.cell.com/cgi/
content/full/118/6/781/DC1). The silencing of HIF-1To further confirm that the JunD-mediated effect on
VEGF-A expression was dependent upon HIF, we used was sufficient to suppress the increase of VEGF-A tran-
junD Regulates Oxidative Stress and Angiogenesis
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Figure 3. Accumulation of HIF-1 and HIF-2 in junD/ Cells
(A) (Left panel) Western blot showing HIF-1 protein in untransfected () wt and junD/ cells or after transfection with the indicated siRNA
(upper gel). Endogenous c-Jun protein was used as a loading control (lower gel). Bar graphs, VEGF-A and glut-1 mRNA levels in wt and
junD/ clones following HIF-1 silencing.
(B) (Left panel) Representative Western blot of nuclear (n) and cytoplasmic (c) extracts of wt or junD/ cells incubated under normoxic (21%
O2) or hypoxic (1% O2) conditions. c-Jun and Paxillin proteins were used as internal controls for nuclear and cytoplasmic extracts, respectively.
(Right panels) Quantification of the signals for HIF-1 and HIF-1-OH proteins under normoxia.
(C) Analysis of HIF-1/VHL interaction using the Far Western method. Whole-cell extracts from normoxic (21%), hypoxic (1%), or DFO-treated
cells were blotted with a radiolabeled VHL protein. Interacting HIF-1 and HIF-2 were identified according to their molecular weight. The
intensity of the signals under normoxia was plotted in the adjacent bar graph.
(D) HIF-1 half-life was estimated upon reoxygenation of wt and junD/ hypoxic cells (t0). Time points of the kinetics of reoxygenation are
indicated in minutes (min). c-Jun was used as an internal control. Bar graphs are expressed as means 	 SD (n  3 cell lines per genotype
in triplicate).
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scription in junD/ fibroblasts. Interestingly, this effect creased. PHDs are absolutely dependent on O2, 2-oxo-
glutarate, and FeII for full activity. Hypoxia and limitationwas not restricted to VEGF-A, since a similar variation
was also detected for glut1, another well-characterized of FeII are thought to allow HIF-1 to escape hydroxyla-
tion and hence proteolysis. Physiological concentra-HIF target gene (Chen et al., 2001).
We next investigated HIF-1protein content and com- tions of ascorbate have been shown to promote PHD
activity by reduction of FeIII into FeII (Knowles et al.,partmentalization by preparing nuclear and cytoplasmic
extracts from wt and junD/ cell lines (Figure 3B). HIF-1 2003). We found that treatment with ascorbate restored
PHD activity in junD/ cells (Figure 4A). Accordingly,was detected in the nuclear extracts in all the cell lines
used and conditions applied. Quantification of HIF-1 ascorbate led to a drastic reduction of HIF-1 protein
levels in junD/ cells, suggesting that changes in thenuclear content under normoxia revealed that the level
of HIF-1 was 3-fold higher in junD/ cell lines relative FeII/FeIII ratio might be responsible for defective PHD
activity in these cells.to wt cells. JunD deletion also resulted in increased HIF-
2 protein levels, although to a lesser extent (Figure 3B). We therefore measured the relative amounts of FeII
by an usual colorimetric assay and observed that FeIIThe accumulation of HIF-1 protein in junD/ cells was
not due to an increased transcription rate, since junD levels were decreased in junD/ fibroblasts relative to
wt cells (Figure 4B). Moreover, treatment of junD/ celldeletion only led to a slight increase of HIF-1 mRNA
level (1.3-fold) (see Supplemental Figure S2 on the Cell lines with ascorbate brought back the FeII amounts to
wt levels. A study of FeIII species was performed usingweb site). Considering that hydroxylation of HIF-1 tar-
gets binding to VHL, we examined the proportion of electron paramagnetic resonance (EPR) spectroscopy
(Figure 4C). EPR is a method of choice for detectingthe hydroxylated form of HIF-1 (HIF-1-OH) using an
antibody that specifically recognizes the hydroxylated compounds with unpaired electrons and has been ex-
tensively used for studying transition metal ions (suchprotein (Chan et al., 2002). Under normoxia, the ratio of
HIF-1-OH to the total HIF-1 protein level was de- as FeIII) in proteins (Ubbink et al., 2002). Positions and
shapes of the EPR signals are greatly dependent on thecreased (4-fold) in all junD/ compared to wt clones
(Figure 3B). The reduced level of HIF-1-OH in junD/ environment of FeIII ion. Moreover, double integration
of these signals determined the relative levels of FeIII.cells implies decreased interaction with VHL, even
though its level and cellular localization did not change The EPR spectrum from wt and junD/ cell lines were
similar and exhibited two high-spin FeIII complexesin junD/ cells (Figure 3B). We followed the interaction
of VHL with HIF-1using the Far Western method (Figure (g  6; g  4.23) and a set of typical low-spin FeIII
complexes (g  2.24; g  2.01; and g  1.93) (Supple-3C). HIF-1/VHL interaction was consistently lower in
junD/ cell lines compared with controls in normoxic mental Figure S3 and data not shown) (Figure 4C). Al-
though FeIII proportion remained rather similar at highand hypoxic conditions. As expected, HIF-1/VHL inter-
action was almost completely lost in wt and junD/ cells spin, the proportion of low-spin FeIII complexes was
increased in junD/ cells compared to wt. Interestingly,treated with desferrioxamine (DFO), an iron chelator that
blocks PHD activity. The same observation was made, iron-dependent dioxygenases exhibit similar low-spin
EPR signals (Rosche et al., 1995). We then tried to deter-although to a lesser extent, with HIF-2. Finally, we
confirmed the decreased HIF-1/VHL interaction in mine the proportion of PHD2 in FeIII oxidation state
(Figure 4D). To define the PHD2-specific EPR spectrum,junD/ cells using coimmunoprecipitation on endoge-
nous proteins (data not shown). we overexpressed it by transient transfection in wt and
junD/ fibroblasts (wtPHD2; junD/PHD2). We ob-A decrease in the interaction with VHL should affect
HIF-1 protein stability. We estimated HIF-1 half-life served a clear increase of low-spin signals in PHD2-
overexpressing cells, confirming that PHD2 exists at aby measuring the time of its degradation upon reoxygen-
ation. The kinetics of HIF-1 degradation were much low-spin state. We displayed, in Figure 4D, the g  1.93
component of these signals. Interestingly, the intensityslower in junD/ cells than in control fibroblasts (Figure
3D). By 180 min post-reoxygenation, HIF-1 protein lev- of the signal corresponding to endogenous or overex-
pressed PHD2 was always higher in junD/ fibroblastsels reached basal levels with the initial differences be-
tween the two cell lines. than in wt cells. These data show that the proportion of
PHD2 in FeIII oxidation state was higher in junD/ cells
than in wt controls.PHD Enzymatic Activity Is Reduced
in junD/ Cells
PHDs catalyze HIF-1 hydroxylation, which controls in- ROS Accumulate in junD/ Cells
FeII can be oxidized by H2O2 to yield FeIII and hydroxylteraction with VHL. No variation in PHD1, PHD2, or PHD3
mRNA levels was observed in junD/ cells (data not radicals by the Fenton reaction: H2O2  FeII → OH• 
OH  FeIII. The increased proportion of FeIII in junD/shown). PHD2 has been recently demonstrated to con-
trol steady-state HIF-1 levels under normoxia (Berra cells suggested that H2O2 may accumulate. The amount
of oxidants in the three junD/ clones was quantifiedet al., 2003). The PHD2 protein levels remained invariant
in junD/ cells compared to wt cells (data not shown). using a cell-permeant molecule that fluoresces when
oxidized by peroxides (CM-H2DCFDA) (Figure 5A). JunDWe next investigated endogenous PHD enzymatic activ-
ity by performing VHL capture assays (Epstein et al., deletion strongly enhanced the ROS-specific signal. We
confirmed that H2O2 accumulated in junD/ cell lines2001) using a HIF-1 peptide as substrate for hydroxyla-
tion by cell extracts (Figure 4A). Strikingly, the capture using a quantitative H2O2 assay (Figure 5B). Because
ascorbate has been proposed to increase FeII levels,of VHL was reproducibly reduced with junD/ extracts
compared to wt, indicating that PHD activity was de- we analyzed its effect on H2O2 production. Ascorbate
junD Regulates Oxidative Stress and Angiogenesis
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Figure 4. Reduced PHD Activity in junD/ Cells
(A) PHD activity is measured by VHL capture assays using a synthetic peptide (mouse HIF-1 residues 556–574) as substrate (upper gel).
Synthetic hydroxylated peptide (peptide OH) is used as positive control. The corresponding amount of HIF-1 is shown in the lower gel with
c-Jun as internal control. Right bar graph represents the quantitative data of the VHL capture assays.
(B) Relative levels of FeII in wt or junD/ cell lines determined by a usual colorimetric assay (see Experimental Procedures).
(C) Relative levels of FeIII determined by EPR spectroscopy. EPR signals at g  6 and g  4.23 stem from high-spin FeIII-linked complexes
in hemoproteins. EPR signals at g  4.23 correspond to high-spin FeIII in nonheme iron proteins or free iron. Signals at g  2.24, 2.01, and
1.93 correspond to low-spin FeIII proteins and characterized some dioxygenases. Relative levels of FeIII were determined by double integration
of the signals and comparison to a standard solution of CuCl2 (see Experimental Procedures).
(D) (Left panel) EPR signals at g  1.93 determine the proportion of PHD2 in FeIII oxidation state in wt and junD/ cells overexpressing or
not overexpressing PHD2 (wt, junD/, wtPHD2; junD/PHD2). (Right panel) Western blot showing PHD2 overexpression in wt and junD/
cells. Bar graphs are expressed as means 	 SD (n  2 cell lines per genotype in triplicate).
treatment abolished H2O2 production and decreased mentation, there were excess FeII ions that also reacted
chemically with H2O2 through the Fenton reaction, ex-HIF-1 protein levels (Figure 5B). Moreover, FeII supple-
mentation (FeCl2) provided FeII ions and restored the plaining that H2O2 levels decreased. Neither ascorbate
nor FeCl2 had an effect on the stability of another short-PHD enzymatic activity in junD/ cells, thereby reducing
HIF-1 protein levels (Figure 5B). Upon FeCl2 supple- lived protein, c-Jun.
Cell
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Figure 5. JunD Modulates ROS Production
(A) (Right panel) Relative ROS levels in wt and junD/ clones are measured by using CM-H2DCFDA fluorescence dye. (Left panel) A representa-
tive sample for three independent FACS analysis is displayed.
(B) (Left panel) Relative H2O2 levels in wt and junD/ cells, in the absence or presence of ascorbate or FeCl2. (Right panel) Western blot
showing the effects of ascorbate or FeCl2 on HIF-1 and c-Jun protein levels.
(C) (Left panel) Relative H2O2 in Ras and RasJunD cell lines. (Right panel) Western blot showing the HIF-1 and c-Jun protein levels. Bar
graphs are expressed as means 	 SD (n  3 cell lines per genotype in triplicate).
Ras promotes the production of ROS (Irani et al., 1997) compared the transcriptome of junD/ versus wt cells.
that may influence PHD activity, similarly to junD dele- Of the 24,000 tested probe sets, 235 genes or ESTs
tion. Since expression of JunD antagonized Ras- were downregulated at least 2-fold in junD/ cells,
induced tumor angiogenesis (Figure 1), we compared whereas 124 genes or ESTs were upregulated at least
H2O2 production in Ras and RasJunD fibroblasts (Fig- 2-fold (D. Gerald, unpublished data). Interestingly,
ure 5C). JunD overexpression decreased H2O2 and HIF- among the genes differentially regulated, we identified
1 protein levels. This explains the decreased VEGF-A a group involved in H2O2 metabolism and regulation of
transcription rate reported above (Figures 2A and 2B). oxidative stress (Figure 6). We confirmed the microarray
data by QRT-PCR (Figure 7A). Among the downregulated
genes were the microsomal glutathione-S-transferase-1Gene Expression Profiling in junD-Deficient Cells
To try to unravel how JunD can influence H2O2 produc- (Mgst-1) (almost undetectable level in junD/ cells) and
the cysteine dioxygenase (Cdo1) (5.5-fold decrease intion, we performed Affymetrix microarray analysis and
junD Regulates Oxidative Stress and Angiogenesis
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Figure 6. Gene Expression Profiling in junD/ Cells
Stress-related genes that are differentially expressed in junD/ compared to control cells are listed. Three hybridizations have been performed
for each cell type. Levels of expression are the mean of values obtained by the triplicate analysis of wt cells. Fold changes correspond to
the differential levels of expression in junD/ fibroblasts versus wt cells. Green, downregulated genes; red, upregulated genes.
junD/ cells compared to wt cells). We have also de- active PHD enzymes by promoting iron oxidation. In-
creased proportion of PHD in the FeIII-inactivated statetected an upregulation of NADPH-oxidase 4 (Nox4)
(3-fold in mutant cells versus wt). limits PHD activity, HIF-1 hydroxylation, and degrada-
tion. Subsequently, HIF-1 accumulation enhancesSeveral genes that protect cells from oxidants were
downregulated in junD-deficient cells, among them VEGF-A transcription. Reciprocally, JunD overexpres-
sion decreases intracellular H2O2 content, alleviates ROSMgst-1, Cdo1, Aldehyde dehydrogenase 2 (ALDH2), and
Prostaglandin I2 synthase (prostacyclin). All these genes toxic effect, and efficiently counteracts Ras-induced an-
giogenesis in tumors.are involved in protection from toxic compounds. Mgst1
encodes a major detoxification enzyme that catalyzes
the conjugation of glutathione (GSH) to a wide variety Discussion
of electrophilic compounds and maintains the cytoplasm
in a reducing environment (Townsend and Tew, 2003). In the present study, we have highlighted a new function
of JunD, a member of the AP-1 family of transcriptionAddition of reduced GSH to junD/ cells decreased H2O2
and HIF-1 amounts to wt levels (Figure 7B). Moreover, factors in oxidative stress and angiogenic switch. Dele-
tion of junD increases H2O2 levels that inhibit PHD enzy-cysteine serves as precursor for the biosynthesis of
GSH. Since the expression of Cdo1, which is involved matic activity by limiting FeII levels. Consequently,
HIF-1 protein accumulates under normoxic conditions,in cysteine homeostasis, was affected by the junD dele-
tion, we have analyzed the effect of adding extra cys- and the transcription of VEGF-A is increased. Recipro-
cally, by limiting the production of oxidants, overexpres-teine to the growth media of junD/ cells. Addition of
extra cysteine also circumvented accumulation of H2O2 sion of JunD reduces VEGF-A expression and exhibits
a potent antiangiogenic effect in tumors derived fromand HIF-1 in junD/ cells (Figure 7B). c-Jun protein
levels did not vary following addition of these reducing Ras-transformed fibroblasts. Finally, by deciphering the
mode of action of JunD, we have provided further in-compounds, excluding general effects of these treat-
ments on protein synthesis. Finally, addition of dipheny- sights into the mechanism of oxygen-independent regu-
lation of PHD enzymatic activity.leneiodonium chloride (DPI), an inhibitor of NADPH-oxi-
dase complexes, in junD/ cells reduced HIF-1 protein
levels (data not shown), suggesting that the upregulation FeII-Dependent Regulation of PHD Enzymes
PHD enzymes require the presence of O2, 2-oxogluta-of Nox4 contributed to H2O2 increase. Conversely, JunD
overexpression in Ras-transformed cells downregulated rate, and FeII at the catalytic site for full activity. Changes
in the cellular levels of any of these cofactors can influ-Nox4 expression (data not shown), confirming that Nox4
played a key role, at least in part, in junD-mediated ence hydoxylase activity and its downstream effects on
the HIF pathway. In this paper, by dissecting the modecontrol of H2O2 levels.
Taken together, these results prompted us to propose of action of JunD, we provide evidence that enhanced
ROS levels promoted oxidation of FeII into FeIII, mostthe following model (Figure 7C). JunD regulates both
genes involved in antioxidative defense and H2O2 pro- probably through the Fenton reaction. Hence, sustained
production of ROS reduces the cellular pool of FeII andduction. JunD deletion causes increased intracellular
H2O2 levels. In its turn, H2O2 reduces the proportion of increases the proportion of PHD in FeIII oxidation state.
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Figure 7. Model for Regulation of ROS and Angiogenesis by JunD
(A) Relative levels of microsomal glutathione S-transferase 1 (Mgst1), cysteine dioxygenase (Cdo1), and NADPH-oxidase 4 (Nox4) in wt and
junD/ cells determined by QRT-PCR.
(B) (Left panel) Relative H2O2 levels in junD/ cells treated with the indicated reducing agents (reduced glutathione (GSH) and extra cysteine).
(Right panel) Corresponding Western blots showing HIF-1 (upper gel) and c-Jun (lower gel) protein levels.
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Accordingly, FeII supplementation reduces the steady- PHD. If so, HIF-1 might accumulate, under normoxic
conditions, in cells deficient for functional mitochondrialstate HIF-1 levels in junD/ cells, similarly to the antiox-
respiratory chain. This has been addressed using a ge-idant compound ascorbate. The effect of ascorbate on
netic approach (Vaux et al., 2001). Analysis of mutantFeII availability has been elegantly validated in a recent
cells lacking mitochondrial DNA (
0 cell lines) revealedstudy (Knowles et al., 2003). Moreover, the iron-depen-
that HIF-1 protein levels were higher in some 
0 celldent regulation of PHD activity has been suggested by
lines than in controls under normoxia. We can now spec-studies using cobalt ions (CoII). Cobalt ions are known
ulate that PHDs are in a FeIII-linked inactivated state into inhibit PHD activity. Iron supplementation is sufficient
these cell lines, although definitive proof requires furtherto antagonize HIF-dependent induction of Epo expres-
investigations. Under hypoxia, lack of O2 completelysion by CoII ions. These results strongly suggest that
shuts down PHD activity and masks iron-dependent reg-CoII competes with iron and prevents FeII accessibility
ulation of the enzymes. Consistently, HIF-1 stabiliza-to the enzymatic site. Our observations validate this
tion by hypoxia remains normal in 
0 cell lines (Srinivasmodel and argue for an iron-mediated regulation of PHD
et al., 2001; Vaux et al., 2001).activity under normoxia.
The FeII-dependent regulation of PHD enzymatic ac-
JunD Protects Cells from Oxidantstivity is most probably shared with other hydroxylases.
Accumulation of ROS, beyond homeostatic thresholds,HIF-1 transcriptional activity is regulated by specific hy-
can cause damage to numerous cellular components,droxylation on an asparagine residue that is catalyzed
including lipids, proteins, and nucleic acids. Under theseby FIH (factor-inhibiting HIF) (Mahon et al., 2001; Lando
conditions, oxidative stress induces an adaptive re-et al., 2002). Like PHD, FIH activity is also dependent
sponse and activates antioxidant defense systems thaton O2, 2-oxoglutarate, and FeII and might be sensitive
facilitate the breakdown of ROS and assure a redoxto limited FeII amounts. JunD deletion, through the gen-
homeostasis. This cellular adaptative response protectseration of ROS compounds, could then inhibit FIH enzy-
cells from death. One potential outcome associated withmatic activity and promote accumulation of transcrip-
chronic oxidative stress in junD/ cells is the previouslytionally active HIF-1 protein.
reported senescence in primary fibroblasts (Weitzman
et al., 2000). Moreover, our study demonstrates that
Role of ROS in the Angiogenic Switch JunD-regulated genes are involved in antioxidative re-
ROS, such as superoxides and peroxides, act as signal sponse. Indeed, previous studies have shown the role
transducers in several systems (for review, see Suzuki of the evolutionary conserved families of mitogen-acti-
et al. [1997]). Previous reports have suggested that H2O2 vated protein kinases (MAPKs) and AP-1 transcription
might be required for the induction of HIF-1 activity and factors in the response to oxidative stress in distinct
the transcription of target genes (Chandel et al., 1998; species. Pap-1, the yeast homolog of AP-1, participates
Agani et al., 2000; Fandrey and Genius, 2000). Produc- in the cellular adaptive response to low levels of H2O2
tion of ROS by cytoplasmic enzymes, including Nox1, (Leppa and Bohmann, 1999; Quinn et al., 2002). Similarly,
a member of the NADPH-oxidase family, has already in fly, JNK signaling pathways coordinate the induction
been shown to induce molecular markers of angiogen- of protective genes that confer tolerance to oxidative
esis, such as VEGF-A (Arbiser et al., 2002). Moreover, stress, alleviate the toxic effects of ROS, and prevent
increased ROS generation by Ras-induced Nox1 is re- aging (Wang et al., 2003). Among the genes identified
quired for oncogenic transformation (Mitsushita et al., in these studies, some (like Mgst1) are also differentially
2004). Our data suggest that, in addition to defect in regulated in junD/ cells. This indicates a conserved
several pathways regulating ROS, NADPH-oxidase protective function of AP-1 against oxidative stress from
complexes may modulate the HIF pathway by triggering yeast to higher vertebrates. A direct role for Jun proteins
ROS production. Moreover, our work uncovers the in the activation of several genes encoding a set of
mechanism of ROS-mediated iron-dependent regula- detoxifying defensive proteins has already been reported
tion of PHD enzymatic activity under normoxia. (Venugopal and Jaiswal, 1998). Antioxidant response ele-
ROS from any other sources might also promote ments (ARE), identified in the promoters of genes encoding
HIF-1 accumulation. Accordingly, it has been shown detoxifying enzymes (such as Mgst), contain active AP-1-
that production of ROS from the endoplasmic reticulum like elements. The nuclear transcription factors Nrf2 and
is involved in the control of HIF-1 protein levels (Liu et Nrf1 have been shown to associate with Jun proteins
al., 2004). Moreover, mitochondria are major O2-con- and positively regulate ARE-mediated expression and
suming organelles and are, at least in some circum- coordinated induction of detoxifying enzymes. Taken
stances, another major source of ROS. Accumulation together, these observations strongly suggest a direct
of ROS due to mitochondrial dysfunction might also role for JunD in the regulation of antioxidant defense
genes that remains to be further investigated.stabilize HIF-1 through iron-mediated inhibition of
(C) (Model) PHDs catalyze hydroxylation of proline residues in HIF-1 under normal O2 conditions. This reaction is required to target HIF-1
for ubiquitination and subsequent proteolysis. PHDs require O2, FeII, and 2-oxoglutarate for function. A lack of one of these components is
sufficient to inhibit PHD enzymatic activity, thereby stabilizing HIF-1. JunD regulates the expression of genes involved in the control of ROS.
Accordingly, junD deletion leads to accumulation of H2O2. H2O2 reduces FeII levels, probably through the Fenton reaction, and inhibits PHD
enzymatic activity. HIF-1 is then stabilized, and the expression of HIF target genes, such as VEGF-A, increases. Reciprocally, overexpression
of JunD is sufficient to reduce the rise of H2O2 mediated by Ras transformation and thereby to inhibit tumor angiogenesis. Bar graphs are
expressed as means 	 SD (n  2 cell lines per genotype in triplicate).
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sequences targeting mouse HIF-1 and D-HIF correspond to theJunD Displays an Antiangiogenic Effect
coding regions 1729–1747 and 2557–2575, relative to the start co-Production of ROS and hypoxic response are key play-
don. Mutation of the human VEGF-A promoter in the HIF bindingers in the occurrence and progression of cancers. The
site proceeded using the QuickChange Site-Directed Mutagenesis
junD/ adult mice do not develop tumors spontaneously Kit (Stratagene) (5CGTG3 → 5AAAG3).
(D. Gerald and F. Mechta-Grigoriou, unpublished data),
suggesting that the protective effect of JunD may only
Analysis of Gene Expressionbe uncovered under stress conditions. We revealed a
Total RNAs were isolated using RNeasy Kit (Qiagen) and treated by
protective effect of JunD in cells transformed by the Ras DNaseI (DNase I RNasefree, Roche) followed by a phenol/chloroform
oncogene, one of the most frequently mutated onco- extraction for DNase inactivation. cDNA were prepared from 1 g
genes in human cancers. Ras-mediated transformation total RNA using random hexaprimers as templates and SuperScript
II (Invitrogen). Absence of DNA contamination was verified by per-enhances ROS production, and treatment with antioxi-
forming amplification without RTase. Quantitative real-time RT-PCRdant molecules decreases the proliferation rate of Ras-
was carried out on an AbiPrism 7000 system using SYBR Green.transformed cell lines (Irani et al., 1997). We previously
The four isoforms that correspond to the spliced variants of VEGF-A
reported that JunD antagonizes Ras-mediated transfor- mRNA were amplified (Tischer et al., 1991). Intron 4 was amplified
mation by modulating cell proliferation (Pfarr et al., to detect VEGF-A primary transcript. The primer sequences are
1994). The present study shows that overexpression of available upon request. For the Affymetrix GeneChip probe array,
three RNA samples were pooled according to their genotype. PooledJunD decreased ROS production in Ras-transformed
RNA were used to synthetize cRNA and hybridized to Affymetrixcells. Thus, we propose that the inhibitory effect of JunD
Murine Genome U74v2 A and B GeneChips. We performed threeon the proliferation of Ras-transformed cell lines is medi-
successive hybridizations to limit experimental variations. Detected
ated in part through the decreased level of ROS. More- probe sets were selected according to the “presence calls” of Mi-
over, Ras oncogene contributes to the growth of solid croarray Suite Software MAS 5.0 (Affymetrix). Fold change of ex-
tumors by a direct effect on cell proliferation and by pression between wt and junD/ cells were established using the
dChip 1.3 software (Li and Wong, 2001). Only significantly changedfacilitating tumor angiogenesis. Indeed, transformation
probe sets (p  0.05) were taken into account.by Ras stabilizes HIF-1 and upregulates VEGF-A ex-
pression as well as other HIF target genes (Bergers and
Benjamin, 2003). Furthermore, a recent study has shown Cell Extracts and Immunoblot Analysis
Cell extracts and Western blotting were performed as in Mechta etthat Ras-induced stabilization of HIF-1 is mediated
al. (1997). Antibodies recognizing mouse c-Jun protein (Lallemandthrough inhibition of HIF hydroxylation (Chan et al.,
et al., 1997), HIF-1 (Richard et al., 2000), hydroxylated HIF-1 (Chan2002). Our data confirm these observations and argue
et al., 2002), pVHL (Pharmingen-Ig32), Paxillin (Transduction Labora-that ROS accumulation in Ras-transformed cells triggers
tories-P13520), and HIF-2 (Abcam-ab199) were used. Blots were
PHD inhibition. We show here that JunD has a major incubated with horseradish peroxidase-conjugated secondary anti-
effect on this process. Indeed, our findings show that body followed by detection with enhanced chemoluminescence
(Amersham) and exposed to autoradiography films. QuantificationsJunD decreased ROS production, restored PHD activity,
were performed using ImageQuant software (Molecular Dynamics).and subsequently reduced significantly Ras-dependent
tumor angiogenesis in vivo. Thus, JunD displays a pro-
tective role against Ras-mediated transformation by Far Western
buffering cells to maintain the redox balance. Far Western analysis was previously described in Guichet et al.
(1997). In brief, the full-length mouse VHL protein was in vitro trans-In conclusion, our data demonstrate that JunD re-
lated using a TNT Transcription/Translation Kit (Promega) to pro-duces the activity of an oxygen sensor in the organism
duce VHL 35S probe. Unincorporated nucleotides were removed inby regulating the expression of genes that function in
a Bio-Rad G25 resin column. Blots were incubated with 100 l
response to oxidative stress and H2O2 metabolism. By labeled VHL protein in 2 ml buffer (0.1 M NaCl, 20 mM Tris (pH
limiting ROS production and HIF-1 protein stability, 7.6), 1 mM EDTA, 1 mM DTT, 10% glycerol, and 1% milk powder)
JunD decreases the transcription of VEGF-A, displays overnight at 4C. Membranes were washed in the above buffer at
4C, dried, autoradiographed, and quantified.antiangiogenic properties, and is able to counteract
Ras-mediated effects. The possibility of modulating
JunD activity may open new opportunities to control In Vitro PHD Activity
VEGF-A expression in physiological and pathological Assay for interaction between VHL and synthetic biotinylated HIF-1
peptides was described in Epstein et al. (2001). Peptides were syn-angiogenesis.
thesized by Millegen. Streptavidin-associated peptides (5 g) were
preincubated with cell lysates (150 g) 1 hr at 28C, washed, and
Experimental Procedures mixed with in vitro 35S-labeled VHL. Bound VHL was analyzed by
SDS-PAGE, autoradiographed, and quantified.
Cell Culture, Transfection, siRNA
Cell culture conditions, Ras, and RasJunD cells (three independent
clones) have already been described in Pfarr et al. (1994). Three Measurement of Intracellular ROS and H2O2
Intracellular ROS generation was assessed using 5-(and 6-)chlo-independently derived immortalized cell lines from wt or junD/
embryos were generated using a conventional 3T3 protocol (Todaro romethyl-2,7-dichlorodihydrofluorescein diacetate (CM-H2DCFDA)
(Molecular Probes). Cells were incubated for 1 hr with 5 M CM-and Green, 1963). Experiments were performed at least in triplicate
on independent cell lines. For hypoxia, cells were incubated in hyp- H2DCFDA, harvested and resuspended at 106 cells/ml in PBS supple-
mented with 7% FCS, and subjected to FACscan analysis. A mini-oxic chamber containing 1% O2 for 3 hr. Treatments of cells were
performed for 4 hr with ascorbate (50 M), FeCl2 (40 M), DFO (100 mum of 30,000 cells was sampled per condition. The concentration
of cellular H2O2 was determined with a quantitative H2O2 assay kit,M), reduced GST (2 mM), or extra cysteine (2 mM) (Sigma). Calcium
phosphate precipitation method was used for transfection. Lucifer- according to the protocol provided by the manufacturer (Sigma-
PD1). Briefly, cells were lysed and incubated at room temperaturease assays were performed using the Dual-Luciferase Reporter
Assay System from Promega. Silencing of HIF-1 by siRNA was with a xylenol orange solution; absorbance was then detected at
560 nm using a spectrophotometer (Bio-Tek).performed as previously described (Berra et al., 2003). The siRNA
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Iron Measurements Cammack, R., and Cooper, C.E. (1993). Electron paramagnetic spec-
troscopy of iron complexes and iron-containing proteins. MethodsFeII levels were measured using a standard analytical procedure
(Feger et al., 2001). In brief, 3  106 cells were lysed in 1 N HCl and Enzymol. 227, 353–384.
incubated with a chromogenic chelator (Na-bathophenanthrolinsul- Chan, D.A., Sutphin, P.D., Denko, N.C., and Giaccia, A.J. (2002).
fonat) (100 M). Absorbance was then detected at 550 nm. EPR Role of prolyl hydroxylation in oncogenically stabilized hypoxia-
spectroscopy has been performed on a Bruker Elexsys 500 spec- inducible factor-1alpha. J. Biol. Chem. 277, 40112–40117.
trometer with an SHQ001 cavity fitted with an ESR900 cooling sys-
Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon,
tem. The microwave source operated at 9.34 GHz. The spectra have
M.C., and Schumacker, P.T. (1998). Mitochondrial reactive oxygen
been recorded at 12 kelvin (K) using 15  106 cells. Cells were
species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci.
harvested in PBS, centrifuged into 3 mm quartz tubes at 1500 rpm,
USA 95, 11715–11720.
and frozen in liquid nitrogen. In general, the spectra were obtained
Chen, C., Pore, N., Behrooz, A., Ismail-Beigi, F., and Maity, A. (2001).as four added scans from 1 to 500 mT using time constant 0.01024
Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interactions, a modulation amplitude of 1.5 mT, and a modulation frequency
between H-ras and hypoxia. J. Biol. Chem. 276, 9519–9525.of 100 kHz. Quantification of the EPR signals was performed by
Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O’Rourke,double integration of the spectra recorded under nonsaturating con-
J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., etditions and by comparison with a standard (30 M CuCl2 and 300
al. (2001). C. elegans EGL-9 and mammalian homologs define aM EDTA) (Cammack and Cooper, 1993).
family of dioxygenases that regulate HIF by prolyl hydroxylation.
Cell 107, 43–54.Tumor Vascularization Assays
Fandrey, J., and Genius, J. (2000). Reactive oxygen species as regu-Tumors were generated as described in Pfarr et al. (1994) using 5 
lators of oxygen dependent gene expression. Adv. Exp. Med. Biol.105 cells per injection. Tumors were dissected out 15–20 days after
475, 153–159.injection. For sectioning, parts of tumors were embedded in gelatine
15% sucrose 7.5% containing matrix, and 20 m sections were Feger, F., Ferry-Dumazet, H., Mamani Matsuda, M., Bordenave, J.,
obtained by using a cryostat. Sections were immunostained using Dupouy, M., Nussler, A.K., Arock, M., Devevey, L., Nafziger, J., Guil-
a specific anti-PECAM-1 antibody (MEC 13.3 from Pharmingen). losson, J.J., et al. (2001). Role of iron in tumor cell protection from
the pro-apoptotic effect of nitric oxide. Cancer Res. 61, 5289–5294.
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